Sixth Annual Neurocritical Care Conference

D7018

+ Add to Google Calendar + Add to Outlook

The purpose of this activity is to provide the participant current, evidenced-based information to assist them in meeting the complex needs of the neurocritical care patient.

This activity is designed for physicians, nurses, advanced practice clinicians, pharmacists and other health care providers who care for neurocritical care patients.

We invite health professionals to submit a Neurosciences related poster abstract for display at the Sixth Annual Neurocritical Care Conference on Friday, Oct. 25, 2024.

Deadline to submit: Friday, Sept. 27

Submit a poster abstract

• 7 a.m. | Check In / Visit Exhibits and Posters
• 7:55 a.m. | Welcome
  Jacquelyn Ryer, DNP, AG-ACNP, CCRN
• 8 a.m. | The Pros and Cons of Extracranial Surgery in the Acute Post Traumatic Brain Injury Period: A Balanced Debate
  Henry Boateng, MD and Sprague William Hazard, MD

  Objectives

  • Review the risks and benefits of performing extra cranial surgery in the acute phase of traumatic brain injury.
• 8:30 a.m. | Updated AHA/ASA Guidelines for the Management of Subarachnoid Hemorrhage
  Frank Jareczek, MD, PhD

  Objectives

  • Discuss the guideline-recommended approach to the diagnostic workup and acute management of aneurysmal subarachnoid hemorrhage.
  • Review the key differences in the newest guidelines as compared to the prior 2012 guidelines.
• 9 a.m. | Case Study – It’s Not Always the Brain
  Lenny Shamus, AGACNP, CRNP

  Objectives

  • Discuss management of intracranial hemorrhage in setting of complex hematological pathophysiology.
  • Discuss assessments of undifferentiated shock.
• 9:15 a.m. | Break/Visit Exhibits and Posters
• 9:30 a.m. | Hyponatremia: The Big Picture
  Mallory Peterson, MD, PhD

  Objectives

  • Differentiate between cerebral salt wasting and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
  • Describe the laboratory values we use to work-up hyponatremia in the intensive care unit.
• 10:15 a.m. | Seizing Special K in Status Epilepticus
  Kayla Bardzel, PharmD, BCCCP

  Objectives

  • Review current guidelines and literature for ketamine use in status epilepticus.
  • Examine risk and benefits of ketamine therapy for status epilepticus.
• 10:45 a.m. | A Review of Anticoagulation Reversal and Updates on Peripheral Administration of Vasopressors
  Hope Hoffman, PharmD, and Jelena Lakic, PharmD

  Objectives

  • Identify common anticoagulants and their reversal agents.
  • Discuss appropriate indications for anticoagulation reversal.
  • Recognize risks and benefits of peripheral vasopressor administration.
  • Review new recommendations and literature regarding peripheral administration of vasopressors.
• 11:15 a.m.–12:15 p.m. | Lunch/Exhibits/Posters/Product Theater
• 11:30 a.m.–12:15 p.m. | Product Theater (not for CME Credit)
  An Overview: Introducing VYVGART® Hytrulo: A Novel Treatment for Adult Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  Dr. Jose Avila
  Certified Neuromuscular Specialist at Geisinger Medical Center
  Director of Neuromuscular and EMG Rotation
  Director of Neurology Outpatient Rotations
  Director of Morning Report
• 12:15 p.m. | Post Intensive Care Syndrome (PICS)
  Christian Lopez Aponte, MD

  Objectives

  • Define epidemiology and its impact on clinical course.
  • Discuss contributing and protective factors for developing PICS.
  • Explain the goal of rehabilitation in caring for patients with PICS.
• 12:45 p.m. | Neurological Critical Care Unit (NCCU) Survival Panel Discussion
  Moderator: Mary Jane Bijelic, MSN, CRNP, AGACNP-BC, CCRN, SCRN

  Objectives

  • Recognize the perspective of the intensive care unit (ICU) stay through the lens of the patient.
  • Determine important aspects of the patient’s experience that the ICU clinician can impact.
• 2 p.m. | Break/Visit Exhibitors and Posters
• 2:15 p.m. | Case Study – Aphasia with Hypoxia
  Josh Bridwell, PA-C

  Objectives

  • Review of emergent therapies for acute ischemic stroke.
  • Review common causes of hypercoagulability.
• 2:30 p.m. | Beyond the Last Breath: Carbogen Apnea Testing in Neurological Determination of Brain Death
  Jefferson Mixell, MBA, RRT, RRT-ACCS

  Objectives

  • Explain the physiological principles behind carbogen apnea testing and its specific application in confirming brain death.
  • Describe the step-by-step procedure for administering carbogen apnea testing, including preparation, patient monitoring, and interpreting results, along with discussing the ethical and clinical implications of diagnosing brain death.
• 3 p.m. | Normothermic Regional Perfusion and Organ Donation
  J. Christopher Zacko, MD

  Objectives

  • Review brain death and developmental coordination disorder.
  • Review normothermic regional perfusion in the context of developmental coordination disorder.
• 3:30 p.m. | Timing of Tracheostomy in Neurocritical Care Patients
  Melissa Linskey Dougherty, MD

  Objectives

  • Discuss the evidence for early tracheostomy in critical care.
  • Discuss controversies with neuroprognostication and tracheostomy.
• 4 p.m. | Adjournment

Christian Lopez Aponte, MD
Assistant Professor, Department of Physical Medicine and Rehabilitation
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Kayla Bardzel, PharmD, BCCCP
Clinical Pharmacist Specialist, Neuroscience ICU
Department of Pharmacy
Penn State Health Milton S. Hershey Medical Center

Henry Boateng, MD
Associate Professor, Department of Orthopaedics and Rehabilitation
Division of Trauma
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Josh Bridwell, PA-C
Neurohospitalist Physician Assistant
Department of Neurology
Penn State Health Milton S. Hershey Medical Center

Melissa Linskey Dougherty, MD
Assistant Professor, Department of Surgery
Division of Trauma, Acute Care and Critical Care Surgery
Assistant Professor, Department of Neurosurgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Sprague William Hazard, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Chief, Division of Neuro-Anesthesia
Division of Critical Care Anesthesia
Associate Professor, Department of Neurosurgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Hope Hoffman, PharmD
PGY-2 Critical Care Pharmacy Resident
Department of Pharmacy
Penn State Health Milton S. Hershey Medical Center

Frank Jareczek, MD, PhD
Neuro-Endovascular Fellow
Department of Neurosurgery
Penn State Health Milton S. Hershey Medical Center

Jelena Lakic, PharmD
PGY-2 Critical Care Pharmacy Resident
Department of Pharmacy
Penn State Health Milton S. Hershey Medical Center

Jefferson Mixell, MBA, RRT, RRT-ACCS
Manager Respiratory Care, Respiratory Therapy
Penn State Health Milton S. Hershey Medical Center

Mallory Peterson, MD, PhD
Neurosurgery Resident
Department of Neurosurgery
Penn State Health Milton S. Hershey Medical Center

Lenny Shamus, AGACNP, CRNP
Department of Neurosurgery
Neuroscience Critical Care Unit
Penn State Health Milton S. Hershey Medical Center

J. Christopher Zacko, MD
Professor and Vice Chair for Quality
Department of Neurosurgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PSNA

This activity has been approved for 6.5 nursing continuing professional development hours. Penn State Milton S. Hershey Medical Center is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Patient Safety

This program includes 6.5 hours of patient safety/risk management education as required by the Pennsylvania State Board of Medicine.

Stroke

This program qualifies for 6 stroke credit hours.

$150 Physicians and Advanced Practice Providers
$100 Nurses and others
$75 Student Fee (email verification of student status to ContinuingEd@pennstatehealth.psu.edu)

The fee includes the cost of instruction, online handout materials and all listed meals.

Payment is required at the time of registration.  If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Thursday, Oct. 24, will incur a $25 late fee.

Cancellations received after Friday, Oct. 18, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, Oct. 22.

Join us in Hershey

Hershey is conveniently located in central Pennsylvania, just 90 minutes from Baltimore and Philadelphia, two hours from Washington, D.C., and three hours from New York City.

• Harrisburg-Area Attractions
• Hershey Attractions
• Tanger Outlets in Hershey
• Historic Gettysburg
• Pennsylvania Dutch and Amish Country

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7018